Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
4 hedge funds and large institutions have $531K invested in Innovator IBD ETF Leaders ETF in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.
50% less funds holding
Funds holding: 8 → 4 (-4)
70% less capital invested
Capital invested by funds: $1.75M → $531K (-$1.22M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$777K |
| 2 |
Jane Street
New York
|
-$211K |
| 3 |
LPL Financial
San Diego,
California
|
-$187K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$37K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$30.3K |
LDRS Hedge Fund Activity: Q2 2020 in Review
4 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q2 2020, worth a combined $531K — down 70% from $1.75M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of LDRS and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $777K sold.
- 4 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q2 2020, down from 8 in Q1 2020.
- Funds reported $531K of Innovator IBD ETF Leaders ETF stock for Q2 2020, down 70% quarter-over-quarter.
- 0 funds opened new Innovator IBD ETF Leaders ETF positions in Q2 2020 and 4 closed out, a net change of -4 holders.
- The largest Innovator IBD ETF Leaders ETF seller in Q2 2020 was Susquehanna International Group, an estimated $777K sold.
Based on aggregated 13F filings for Q2 2020.